about
A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research.Cisplatin is retained in the cochlea indefinitely following chemotherapy.Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5A.Revisiting the role of ABC transporters in multidrug-resistant cancer.A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase.Structure-based engineering of irreversible inhibitors against histone lysine demethylase KDM5AHigh-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoproteinIdentification of Activators of Human Fumarate Hydratase by Quantitative High-Throughput ScreeningInteraction of the N terminus of ADP-ribosylation factor with the PH domain of the GTPase-activating protein ASAP1 requires phosphatidylinositol 4,5-bisphosphateKeeping It Clean: The Cell Culture Quality Control Experience at the National Center for Advancing Translational SciencesMycoplasma Infection Mediates Sensitivity of Multidrug-Resistant Cell Lines to Tiopronin: A Cautionary TaleCorrection to A Drug of Such Damned Nature. Challenges and Opportunities in Translational Platinum Drug ResearchEvaluation of 11C-NR2B-SMe and its Enantiomers as PET Radioligands for Imaging the NR2B Subunit within the NMDA Receptor Complex in RatsTargeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing SarcomaHigh-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing SarcomaPhysiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screensCytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput ScreeningThe SARS-CoV-2 cytopathic effect is blocked with autophagy modulatorsStandardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood samplingAn OpenData portal to share COVID-19 drug repurposing data in real time
P50
Q38757744-4724793E-6359-4705-A5B9-7637B22D09D6Q46002451-9D6F2E19-BFE1-44FF-84BB-61E7044A0C46Q47626141-FF7DB6C1-0A45-42A3-A085-DC472199B465Q52356161-23E0640A-4534-47A0-AE80-555695D615F7Q52593092-42166791-2395-40FA-BA9F-1F9AAAA1AA35Q55311678-038B6542-7A75-4787-8F29-18FE4AE1CCECQ58614403-CB2FF930-3B51-48F7-8822-243E9189E995Q58977715-6573190F-8A29-4E9F-825A-865F0BD455B0Q90083275-1BD0635F-D700-4200-A379-215AD5C6D4AFQ90113091-BD4A644E-F036-490E-B7FF-5792D234A1BCQ90574043-38CD2269-1935-49D4-B759-146C96AB5A06Q90793579-AC23EB28-EEFF-4881-9A7D-FA4A04C92248Q91188889-AAE100C3-DD5A-4D97-8FA6-D08BE913D48BQ91807117-540BA11F-0188-4C13-B8E9-B92B35798C72Q92563018-9A47B9F1-DD7F-43C9-BFE4-29119395F7A2Q92733993-EDC2EABA-4671-45DE-8D7D-6D71743F21DAQ93064614-41A8B006-EEDE-4FBD-B4DD-FD78F2AA588DQ93085445-1DC5536A-CE0F-413F-99D4-94E9B2784FF3Q93195832-4C9E18AD-98CE-4FF3-825B-9459EC896B0BQ95611618-37C294FB-2625-4A1D-A358-0B1677D4D54CQ95625741-A2C20599-F3DB-46AF-935F-4A833A55ED3FQ96223461-9BB75666-8BE5-407E-B4D4-83DE362E1B7B
P50
description
medical researcher
@en
wetenschapper
@nl
name
Matthew D. Hall
@af
Matthew D. Hall
@ast
Matthew D. Hall
@ca
Matthew D. Hall
@cs
Matthew D. Hall
@da
Matthew D. Hall
@de
Matthew D. Hall
@en
Matthew D. Hall
@en-ca
Matthew D. Hall
@en-gb
Matthew D. Hall
@es
type
label
Matthew D. Hall
@af
Matthew D. Hall
@ast
Matthew D. Hall
@ca
Matthew D. Hall
@cs
Matthew D. Hall
@da
Matthew D. Hall
@de
Matthew D. Hall
@en
Matthew D. Hall
@en-ca
Matthew D. Hall
@en-gb
Matthew D. Hall
@es
prefLabel
Matthew D. Hall
@af
Matthew D. Hall
@ast
Matthew D. Hall
@ca
Matthew D. Hall
@cs
Matthew D. Hall
@da
Matthew D. Hall
@de
Matthew D. Hall
@en
Matthew D. Hall
@en-ca
Matthew D. Hall
@en-gb
Matthew D. Hall
@es
P31
P496
0000-0002-5073-442X